Abstract
Results
Seven patients were excluded (five with serum creatinine greater than 2 mg/dl, one who did not return for visits, and another because of the incorporation of calcium-channel blockers after azithromycin treatment). Details of the 31 patients included in the trial are given in Table 1 ; 19/31 (61%) and 1/31 (3%) patients received calcium-channel blockers or phenytoin respectively during the whole study.
At the beginning of therapy, 11 patients had a gingival hyperplasia score of 3, 17 had a score of 2, and 3 a score of 1. The mean maintenance dose of cyclosporin during the previous month (mg/kg/day) was 3. 01±1.28 (0.85-6.80 ). The degree of gingival hyperplasia was unrelated to cyclosporin dose (2.67±0.7 mg/kg/day for score 3 vs 3.4±1.5 mg/kg/day for score 2, P=0.1), or to cyclosporin blood levels (153±30 ng/ml for score 3 vs 147±31 ng/ml for score 2, P=0.66). The cyclosporin dose was kept constant throughout the period of study (3±1.2, 3±1.1, 3±1.1, 2.9±1.1, and 2.9±1.1 mg/kg/day at baseline, 7, 30, 90 and 180 days respectively, P=0.7).
Twelve patients had poor and 19 had good oral hygiene when enrolled in the study; 66% (8/12 ) of the patients with poor oral hygiene had a score of 3, vs 21% (4/19) of patients with good oral hygiene (P= 0.02). Gingival hyperplasia improved in all treated patients 1, mild gingival overgrowth; (B) score 2, moderate overgrowth; and throughout the study (P<0.0001, F=95.96, Friedman (C ) score 3, severe overgrowth. test). Improvement was evident 7 days after the beginning of therapy in all except two patients who had an initial score of 3. All patients, however, showed and evolution of gingival hyperplasia were determined on improvement at the 30th and 180th days, including the days 0 (pretreatment), 7, 30, 90 and 180. The degree of two previous patients without initial improvement gingival bleeding was determined using triangular toothpicks ( Table 2 ). The degree of improvement was enhanced (5) at day 0. The day bleeding ceased was determined by the patient, and this was verified using the same method on the with a lower degree of initial hyperplasia. day 7 visit. The degree of oral hygiene at the beginning of On the 7th day of therapy, 9/11 patients with an treatment was noted as poor or good and the patients were initial score of 3 improved to classification 2, with two instructed on adequate oral hygiene (brushing, flossing) patients remaining at 3. In the group of patients with during the period of the study. Other bleeding indexes and an initial score of 2, 15/17 were scored at 1, and 2/17 plaque index were not determined. Analytic determinations including cyclosporin blood levels (monoclonal antibodies, Tdx, Abbott), serum creatinine, and ALT were simultan- Table 1 . Patient data eously carried out.
The groups (score 3 vs score 2) were compared using the Sex (male/female) of score of gingival overgrowth throughout the study). Calcium-channel blockers Evolution of the disease after 7 and 180 days of treatment Nifedipine 13 was analysed using Wilcoxon signed rank test. Results are Amlodipine 6 expressed as the mean±SD. Differences were considered Phenytoin 1 significant when the two-tailed P value was <0.05. the benefits. After short-term therapy (7 days after the sia, since several patients with excellent oral hygiene had an initial score of 3, as others authors have also noted [8] . improved to a score of 0. All three patients with an initial score of 1 improved to a score of 0 (P<0.0001, There are only two articles about the improvement of gingival overgrowth with drug therapy. In 1994, Wilcoxon signed rank test). At the end of the study (180th day), only 45% (5/11) patients with an initial Wong and colleagues [9] described four cases of cyclosporin-induced gingival hyperplasia which resolved score of 3 achieved a final score of 0, while 88% (15/17) of those with an initial score of 2 and 100% (3/3) of after 7 day treatment with 400 mg/day of metronidazole. Gingival hyperplasia disappeared after 3-4 weeks those with an initial score of 1 were without gingival hyperplasia (P<0.0001, Wilcoxon signed rank test).
of treatment. In two of these patients gingival hyperplasia recurred 1 year later, but then it responded again The degree of oral hygiene also affected the response to treatment. At the end of study, only 50% (6/12) of to a second course of metronidazole therapy.
Wahlstrom and colleagues [4] described two further patients with poor oral hygiene developed a score of 0, as opposed to 90% (17/19) of those with good oral cases of gingival hyperplasia that improved after treatment with azithromycin. Therapy consisted of a 5-day hygiene (P=0.03, Fisher's exact test).
In 27 patients gingival hyperplasia did not recur, course of azithromycin (at an initial dose of 500 mg, followed by a daily dose of 250 mg for 4 days). while three patients needed a second course of treatment, and 1 patient needed gingival surgery after an Azithromicin was used for other reasons, and the regression of the gum overgrowth was noted incidentinitial phase of improvement. The latter 4 patients had pre-treatment scores of 3.
ally a few months later. The mechanism by which these drugs may improve Twenty eight patients suffered gingival bleeding after brushing their teeth. All of them stopped bleeding after gingival hyperplasia is unknown. Although both have an antibacterial effect, they belong to different groups 2.2±1.2 days (range 1-7).
Azithromycin was well tolerated and no adverse with different mechanisms of action. Moreover, no pathogen was identified in gum scrapings [10] , and effects were observed. The levels of cyclosporin (139±36, 153±37, and 146±38 ng/dl, P=0.06), this disease does not appear in patients treated with other immunosuppressive drugs [11] . On the other serum creatinine (120±29, 121±28 and 122±27
